Tenderfy

Supply, Delivery, Installation, Commissioning and Post-Warranty Maintenance of Digital PCR (dPCR) System for Haemoto-oncology Assays

Pasūtītājs
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
Publicēts
2026-11-16
Termiņš
2026-12-16T13:00:00+00:00
Avoti
UK_FTS
Vērtība
270000.0 GBP

Apraksts

Apraksts ir avota valodā.

The Cambridge Genomics Lab provides a comprehensive range of genomic testing for patients with haematological malignancies (haem-onc), with solid cancer, and with rare disease. In the haem-onc setting, we currently utilise a range of molecular techniques including Next-generation sequencing, quantitative PCR, and fragment analysis to identify and monitor clinically significant genomic alterations. However, there is an increasing requirement for high sensitivity, quantitative molecular testing both to support diagnosis and for disease monitoring / assessment of therapeutic response. We are therefore looking to procure a Digital / Digital Droplet (dPCR / ddPCR) system to complement the laboratory’s existing molecular testing capabilities. This would also intend to facilitate the consolidation of multiple existing assays and methodologies onto a single technology platform.

CPV: 38950000

Dalība

Paziņojumu priekšskatījumi ir bez maksas. Saitēm uz oficiālajiem paziņojumiem un dokumentiem, būvatļaujām un personīgai MCP piekļuvei nepieciešama aktīva maksas dalība.

Lasīt